HANTAVIRUS
Bill’s Commentary:
“Imagine that!”
U.S. Army Clinical Trial with Hantavirus DNA Gene Therapy Inection-98% of Participants Suffered Adverse Events
According to Nicolas Hulscher (Epidemeologist and Foundation Administrator at the McCullough Foundation) via LinkedIn…’The US Army already ran a clinical trial with an Andes strain hantavirus DNA gene-therapy injection — the exact same strain behind the cruise ship outbreak.
98% of participants suffered adverse events.
BillHolter.com 
Thank you pamelamoves@gmail.com
LikeLike
The rest of the story:
Conclusions
This first-in-human candidate HPS vaccine trial demonstrated that an ANDV DNA vaccine was safe and induced a robust, durable immune response.
Clinical Trials Registration. NCT03682107.
LikeLike